(3b)-胆甾-5-烯-3-基氢过氧化物 | 2058-59-5

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 类固醇和类固醇衍生物
• 中文名称: (3b)-胆甾-5-烯-3-基氢过氧化物
• 英文名称: Cholesteryl ester hydroperoxide
• 英文别名: (3S,8S,9S,10R,13R,14S,17R)-3-hydroperoxy-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene
• CAS: 2058-59-5
• 化学式: C₂₇H₄₆O₂
• 分子量: 402.7
• InChiKey: JMMMHJWHJMBHOK-DPAQBDIFSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  8.6
• 重原子数：
  29
• 可旋转键数：
  6
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.93
• 拓扑面积：
  29.5
• 氢给体数：
  1
• 氢受体数：
  2

文献信息

• SYSTEMS AND METHODS FOR DISTINGUISHING BETWEEN AUTISM SPECTRUM DISORDERS (ASD) AND NON-ASD DEVELOPMENTAL DELAY
  申请人：SynapDx Corporation

  公开号：US20150024947A1

  公开（公告）日：2015-01-22

  Methods and systems are presented herein to distinguish children with Autism Spectrum Disorders (ASD) from those with other forms of developmental delay (DD) based on patterns of gene expression levels in blood.
• LIPID NANOPARTICLE FORMULATION
  申请人：ModernaTX, Inc.

  公开号：US20200129445A1

  公开（公告）日：2020-04-30

  The disclosure features novel lipids and compositions involving the same. Nanoparticle compositions include an ionizable lipid, a phospholipid, a first sterol or a tocopherol, and optionally a second sterol different from the first sterol. Nanoparticle compositions further including therapeutic and/or prophylactics such as RNA are useful in the delivery of therapeutic and/or prophylactics to mammalian cells or organs to, for example, regulate polypeptide, protein, or gene expression.